发明名称 HYDROCHLORIDE SALT OF ((1S,2S,4R)-4-{4-[(1S)-2,3-DIHYDRO-1H-INDEN-1-YLAMINO]-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL}-2-HYDROXYCYCLOPENTYL)METHYL SULFAMATE
摘要 Disclosed is a compound of formula ( I ): crystalline forms thereof, and solvates thereof; pharmaceutical compositions comprising a pharmaceutically effective amount of the compound of formula ( I ), or a crystalline form thereof, or a solvate thereof, and a pharmaceutically acceptable carrier or diluent; and the use of a compound of formula ( I ), or a crystalline form thereof, or a solvate thereof, for treating a patient suffering from, or subject to, a pathological condition capable of being ameliorated by inhibiting an E1 activating enzyme, particularly NAE, including, e.g., cancer.
申请公布号 EP3091020(A3) 申请公布日期 2017.01.11
申请号 EP20160159438 申请日期 2010.05.13
申请人 Millennium Pharmaceuticals, Inc. 发明人 Armitage, Ian G;Chopra, Reenu;Cooper, Martin Ian;Langston, Marianne;Langston, Steven P.;Vyskocil, Stepan
分类号 C07D487/04;A61K31/52;A61P35/00 主分类号 C07D487/04
代理机构 代理人
主权项
地址